Illumina, Inc. (NASDAQ:ILMN) J.P. Morgan 42nd Annual Healthcare Conference January 9, 2024 12:00 PM ET Company Participants Jacob Thaysen - CEO Joydeep Goswami - CFO, Chief Strategy and Corporate Development Officer Conference Call Participants Rachel Vatnsdal - J.P. Morgan Rachel Vatnsdal Perfect. Good morning, everyone. This is Rachel Vatnsdal with the Life Science Tools and Diagnostics team, I'm here with Illumina up on stage. So as these sessions are, it's going to be 40 minutes, roughly 20 minutes of p ...

BioNTech SE (NASDAQ:BNTX) 42nd Annual J.P. Morgan Healthcare Conference January 9, 2024 12:00 PM ET Company Participants Ugur Sahin - CEO Ryan Richardson - Chief Strategy Officer Conference Call Participants Jess Fye - J.P. Morgan Jess Fye Great. Good morning, everyone. My name is Jess Fye. I am a Senior Biotech Analyst at J.P. Morgan, and we’re continuing the conference today with BioNTech. I am joined by the company's CEO, Dr. Ugur Sahin. He is going to give a presentation on the company and then we are g ...

Novartis AG (NYSE:NVS) 2024 J.P. Morgan 42nd Annual Healthcare Conference Call January 8, 2024 9:00 AM ET Company Participants Vas Narasimhan - Chief Executive Officer Conference Call Participants Richard Vosser - J.P. Morgan Richard Vosser Welcome to the Novartis presentation at the 42nd J.P. Morgan Healthcare Conference. I'm Richard Vosser, European Pharma Analyst with J.P. Morgan. It's my great pleasure to welcome Vas Narasimhan, the CEO of Novartis today. Before I hand over to Vas, I'll just everyone; w ...

GSK plc (NYSE:GSK) 42nd Annual JP Morgan Healthcare Conference January 9, 2024 10:30 AM ET Company Participants Emma Walmsley - Chief Executive Officer Luke Miels - Chief Commercial Officer Tony Wood - Chief Scientific Officer Conference Call Participants James Gordon - JPMorgan James Gordon Good morning. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the GSK presentation. You're going to hear from GSK CEO, Emma Walmsley. Thanks a lot for join ...

Novo Nordisk A/S (NVO) J.P. Morgan 42nd Annual Healthcare Conference January 9, 2024 12:45 PM ET Company Participants Lars Fruergaard Jorgensen - President & Chief Executive Officer Conference Call Participants Richard Vosser - JPMorgan Richard Vosser Welcome to the Novo Nordisk session at the 2024 JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to welcome the CEO of Novo, Lars Fruergaard Jorgensen to the conference for the first time. So ...

Thermo Fisher Scientific, Inc. (NYSE:TMO) 42nd Annual J.P. Morgan Healthcare Conference January 9, 2023 11:15 AM ET Company Participants Marc Casper – Chief Executive Officer Conference Call Participants Rachel Vatnsdal – J.P. Morgan Rachel Vatnsdal Perfect. Good morning everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at J.P. Morgan. I'm joined on stage by Marc Casper, CEO of Thermo Fisher. So as we typically do, this is going to be a 40 minute session. First of it, h ...

Agilent Technologies, Inc. (NYSE:A) J.P. Morgan 42nd Annual Healthcare Conference January 9, 2024 12:45 PM ET Company Participants Mike McMullen - President & Chief Executive Officer Bob McMahon - Chief Financial Officer Conference Call Participants Rachel Vatnsdal - JPMorgan Rachel Vatnsdal Hi. Good morning, everyone. This is Rachel Vatnsdal with the Life Science Tools and Diagnostics team here at JPMorgan. I'm joined by the Agilent management team on stage as these sessions typically are, it's 40 minutes, ...

The Cigna Group (NYSE:CI) J.P. Morgan 42nd Annual Healthcare Conference January 9, 2024 10:30 AM ET Company Participants David Cordani - President, Chief Executive Officer & Chair Eric Palmer - Chief Executive Officer & President, Evernorth Conference Call Participants Lisa Gill - JPMorgan Lisa Gill Good Morning. My name is Lisa Gill, and I'm Head of Healthcare Services for JPMorgan. It is with great pleasure this morning that we have with us Cigna Health. With us this morning, we have CEO, David Cordani; a ...

Novavax, Inc. (NASDAQ:NVAX) JPMorgan 42nd Annual Healthcare Conference January 8, 2024 8:15 PM ET Company Participants John Jacobs - President and CEO John Trizzino - Chief Commercial Officer & Chief Business Officer James Kelly - CFO Filip Dubovsky - President of Research & Development Conference Call Participants Eric Joseph - JPMorgan Eric Joseph All right, okay. We'll get started here. I'm Eric Joseph, Senior Biotech Analyst with JPMorgan. And our next presenting company is Novavax. Presenting on behalf ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) J.P. Morgan 42nd Annual Global Healthcare Conference January 8, 2024 11:15 AM ET Company Participants Richard Francis - President, CEO & Director Conference Call Participants Christopher Schott - JPMorgan Christopher Schott Good morning, everybody. I'm Chris Schott, Firm Analyst at JPMorgan and it's my pleasure to be introducing Teva today. From the company we have CEO, Richard Francis. Richard joined Teva roughly a year ago, can be said a very productive 2 ...